PENTOXIFYLLINE AND WELLBEING IN PATIENTS WITH CANCER

被引:44
作者
DEZUBE, BJ
FRIDOVICHKEIL, JL
BOUVARD, I
LANGE, RF
PARDEE, AB
机构
[1] HARVARD UNIV, SCH MED, DANA FARBER CANC INST, DEPT MED, BOSTON, MA 02115 USA
[2] BETH ISRAEL HOSP, DEPT MED, DIV MED ONCOL, BOSTON, MA 02215 USA
关键词
D O I
10.1016/0140-6736(90)90450-J
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:662 / 662
页数:1
相关论文
共 6 条
[1]  
BALKWILL F, 1987, LANCET, V2, P1229
[2]  
BAUER KA, 1989, BLOOD, V74, P165
[3]  
BEUTLER B, 1987, NEW ENGL J MED, V316, P379
[4]   PENTOXIFYLLINE PREVENTS TUMOR NECROSIS FACTOR-INDUCED LUNG INJURY [J].
LILLY, CM ;
SANDHU, JS ;
ISHIZAKA, A ;
HARADA, H ;
YONEMARU, M ;
LARRICK, JW ;
SHI, TX ;
OHANLEY, PT ;
RAFFIN, TA .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1989, 139 (06) :1361-1368
[5]   CELLULAR AND MOLECULAR REGULATION OF TUMOR NECROSIS FACTOR-ALPHA PRODUCTION BY PENTOXIFYLLINE [J].
STRIETER, RM ;
REMICK, DG ;
WARD, PA ;
SPENGLER, RN ;
LYNCH, JP ;
LARRICK, J ;
KUNKEL, SL .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 155 (03) :1230-1236
[6]   PENTOXIFYLLINE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND ITS THERAPEUTIC EFFICACY [J].
WARD, A ;
CLISSOLD, SP .
DRUGS, 1987, 34 (01) :50-97